Charles River Laboratories International, Inc. (CRL) stock chart
CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30185% above fair value
$337.97−2.84 (-0.83%)
Close on Nov 13, 2026Market cap $16.13BP/E 397.6Yield –
Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.
See a number that looks wrong?